0001553610-20-000004.txt : 20200522 0001553610-20-000004.hdr.sgml : 20200522 20200522082319 ACCESSION NUMBER: 0001553610-20-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 EFFECTIVENESS DATE: 20200522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367515 FILM NUMBER: 20903713 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001389545 NovaBay Pharmaceuticals, Inc. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 (510) 899-8800 DELAWARE NOVACAL PHARMACEUTICALS, INC. None Corporation true JUSTIN HALL 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Executive Officer CHIEF EXECUTIVE OFFICER ANDREW JONES 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Executive Officer CHIEF FINANCIAL OFFICER PAUL FREIMAN 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Director MIJIA (BOB) WU 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Director XINZHOU (PAUL) LI 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Director YENYOU (JEFF) ZHENG 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Director XIAOPEI (RAY) WANG 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Director SWAN SIT 2000 POWELL STREET SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-13 false true true false 0 1731030 1030 1730000 SEE THE DESCRIPTION OF THE SERVICES AGREEMENT REGARDING THE WARRANTS TO BE ISSUED AND THE SECURITIES PURCHASE AGREEMENT REGARDING 1,000 SHARES OF COMMON STOCK TO BE ISSUED IN THE FORM 8-K FILED WITH THE SEC ON MAY 18, 2020. false 0 0 0 0 false NovaBay Pharmaceuticals, Inc. JUSTIN M. HALL JUSTIN M. HALL PRESIDENT, CHIEF EXECUTIVE OFFICER AND GENERAL COUNSEL 2020-05-21